Oct 26, 2012
By Bob Komsic
Researchers found that among patients with the mutations, those who regularly took aspirin lived longer than those who didn’t.
About one-sixth of all colon cancer patients have the mutated gene and might be helped by aspirin.
The Harvard Medical School study is in this week’s New England Journal of Medicine.
To learn about advertising opportunities with Zoomer Radio use the link below: